[CLSTR]
< Back to situation

[REVISION HISTORY]

CBL-514 clinical trials for fat reduction

Updated 1 time since CLSTR started tracking revisions of this situation.

What changed

2026-10-19 09:16 UTC → 2026-10-24 03:31 UTC · added removed

Clinical trials for an experimental injection known as CBL-514 CBL-514, developed by Caliway Biopharmaceuticals, have demonstrated potential in reducing visceral and subcutaneous fat. The treatment functions by inducing apoptosis, a process where fat cells are triggered to self-destruct, rather than simply reducing the volume of existing cells. Initial reports This mechanism distinguishes it from existing weight-loss medications like Wegovy or Mounjaro. Phase 2 clinical trials, specifically studies CBL-0204 and CBL-0205, indicated that participants receiving injections every three weeks saw an average reduction in visceral fat volume of approximately 12% following a 12-week period. the treatment effectively reduces subcutaneous fat. Follow-up analysis of a subgroup of 41 participants confirmed these findings, noting that while the treatment group those receiving injections saw an average reduction of 12.01% in visceral fat, fat volume of 12.01% four weeks after the final injection, while the placebo group experienced an average increase of 5.68%. Researchers approximately 5.7%. Researchers, including endocrinologist Timothy Garvey from the University of Alabama at Birmingham, suggest that by reducing the total number of fat cells, the treatment may help prevent the weight regain. Additionally, early regain often seen after stopping traditional weight-loss drugs. While the drug was reported to be well-tolerated, common side effects included temporary swelling and pain. These results indicate were presented at a scientific meeting but have not yet undergone formal peer review. Early data also suggest that the reduction of visceral fat may lead to improvements in cholesterol levels and blood pressure.

Versions

  1. 2026-10-24 03:31 UTC CBL-514 clinical trials for fat reduction
  2. 2026-10-19 09:16 UTC CBL-514 clinical trials for fat reduction

Only revisions since CLSTR began indexing content versions appear here. Select a version to see what changed compared to the one before it.